If you have read our blogs before you have probably read one of our posts about how there is no standard protocol for Platelet Rich Plasma (PRP) Therapy, which makes it difficult for patients as they determine the best treatment option for them. Not only are there multiple Platelet Rich Plasma (PRP) kits used, with varying amounts of blood drawn and number of spins, but the protocol that practices follow can differ.
For instance, our research has shown that it is best to start patients with a protocol of one treatment a month for three months. We pride ourselves on making sure that our protocols are based on the best available research and this constant review led us to our exclusive Optimal Platelet Concentration™ Therapy treatment that we started to offer this year.
While we are confident in our treatment plans, it is always great when we come across more research that confirms our protocols, which is why we were excited to see the results of a recent study released in the October 2019 edition of the journal of Dermatologic Surgery titled Platelet-Rich Plasma as a Treatment for Androgenetic Alopecia.
While this study in the journal of Dermatologic Surgery was not a new study on Platelet Rich Plasma (PRP) Therapy, instead it was a review of 10 of the more substantive studies on Platelet Rich Plasma (PRP) therapy to evaluate the effectiveness of Platelet Rich Plasma (PRP) therapy. Based on the review of previous studies it found a few essential factors that the authors believe are important for successful treatment with Platelet Rich Plasma (PRP) Therapy:
| Initial Treatment | It is recommended that patients start with one treatment a month for three months for a total of three treatments followed by a maintenance regimen |
| Activation of Platelets | Activating the platelets with calcium chloride or scalp needling is recommended |
| Platelet Concentration | The optimal concentration of platelets for the Platelet Rich Plasma (PRP) is 1.5 billion per ml |
These findings are important, because they are consistent with our current treatment plans, specifically the Optimal Platelet Concentration™ Therapy. With our Optimal Platelet Concentration™ Therapy we are conducting a platelet count on the day of treatment, which allows us to customize the treatment to ensure that we are reaching the optimal concentration of 1.5 billion per ml. Our goal is to always provide the best possible treatments backed by research and this study confirms that we are doing that.
Posted by Your Medi Tresse Team
